NMDA Receptors Play an Anti-aggregating Role in Human Platelets

Summary

Receptors for different monoamines, peptides and other neurohormones are present in the plasma membrane of platelets, and the sophisticated process of haemostasis is regulated by the interplay of their physiologic agonists (1). The recent report of a platelet binding* site for phencyclidine (2) suggested a possible role of N-methyl-D-aspartate (NMDA) receptors in platelet function. Isotherms of [3H]-glutamate (GLU), [³H]-CGP-39653, [3H]-glycine (GLY) and [³H]-MK-801 carried out in platelet membranes yielded Bmax and Kd values for these ligands similar to those present in neurons, and NMDA only partially displaced [³H]-GLU. In neurons [³H]-MK-801 binding is potentiated by GLU and/or GLY and, being specific for the open NMDA receptor channel species, it has a functional meaning. In platelet membranes neither GLU and/or GLY increased [³H]-MK-801 binding; thus suggesting that NMDA receptors in platelets are different from those present in neurons. GLU or NMDA alone did not induce platelet aggregation. However, both amino acids were antagonistic on the aggregating activity of arachidonic acid (AA), NMDA being 3 orders of magnitude more active than GLU, and NMDA also antagonized adenosine diphosphate (ADP) and platelet aggregating factor (PAF) induced platelet aggregation. Finally, NMDA increased cAMP levels in intact platelets, and such an effect did not occur in a Ca²⁺-free medium; yet, cAMP increase was not antagonized by the calmodulin inhibitor trifluoperazine (TFP). It was concluded that platelet membranes carry an NMDA receptor, functionally distinct from the neuronal one, which seems to play an anti-aggregating role.

• References

• 1 Colman RW, Marder VJ, Salzman EW, Hirsh J. Overview of hemostasis. In: “Hemostasis and thrombosis, basic principles and clinical practice” Colman RW, Hirsh J, Marder VJ, Salzman EW. Philadelphia: J. B. Lippincott Company; 1994: 3-18
• 2 Jamieson GA, Agrawal AK, Greco NJ, Tenner TE, Jones GD, Rice KC, Jacobson AE, White JG, Tandon NN. Phencyclidine binds to blood platelets with high affinity and specifically inhibits their activation by adrenaline. Biochem J 1992; 285: 35-39
• 3 Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 1989; 29: 365-402
• 4 Watkins JC. The NMDA receptor concept: origins and development. In: “The NMDA Receptor” Watkins JC, Collingridge GL. (ed). Oxford, New York, Tokyo: IRL Press; 1989: 1-17
• 5 Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987; 325: 529-531
• 6 McDonald JW, Johnston MV. Physiological and pathophysiological role of excitatory amino acids during central nervous system development. Brain Res Rev 1990; 15: 41-70
• 7 Daw NW, G. Stein PS, Fox K. The role of NMDA receptors in information processing. Annu Rev Neurosci 1993; 16: 207-222
• 8 Olney JW. Excitotoxic amino acids and neuropsychiatric disorders. Annu Rev Pharmacol Toxicol 1990; 30: 47-71
• 9 Erdo SL. Excitatory amino acids receptors in the mammalian periphery. Trends Pharmacol Sci 1991; 12: 426-429
• 10 Almazov VA, Popov YG, Gorodinskii AI, Mikhailova OA, Dambinova SA, Gurevich VS. Sites of high affinity binding of L-[3H]-glutamic acid in human platelets. New type of platelet receptors. Biokhimiya 1988; 53: 848-52
• 11 Wong EHF, Kemp JA, Pristley T, Knight AR, Woodruff GN, Iversen LL. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci 1986; 83: 7104-7018
• 12 Jamieson GA, Raulli RE, Jackson B. Phencyclidine inhibits epinephrine-stimulated platelet aggregation independently of high affinity N-methyl-D-aspartate (NMDA)-type glutamate receptors. Biochim Biophys Acta 1994; 1224: 175-180
• 13 Bom GUR, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168: 178-186
• 14 Franconi F, Miceli M, Bennardini F, Mattana A, Covarrubias J, Seghieri G. Taurine potentiates the antiaggregating action of aspirin and indomethacyn. in: Taurine: nutritional value and mechanism of action Lombardini JB, Schaffer SW, Azuma J. (Ed) N. Y. London: Plenum Press; 1992: 181-186
• 15 Bristow DR, Bowery NG, Woodruff GN. Light microscopic autoradiographic localisation of [3H]-glycine and [3H]-strichnine binding sites in rat brain. Europ J Pharmacol 1986; 126: 303-307
• 16 Sills MA, Fagg G, Pozza M, Angst C, Brundish DE, Hurt SD, Wilusz EJ, Williams M. [³H]-CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain. Europ J Pharmacol 1991; 192: 19-24
• 17 Davies JD, Francis AA, Jones AW, Watkins JC. 2-Amino-5-phosphonova-lerate (2-APV), a potent and selective antagonist of amino acid induced and synaptic excitation. Neurosci Lett 1981; 21: 77-81
• 18 Snell LD, Tabakoff B, Hoffman PL. Radioligand binding to the N-methyl-D-aspartate receptor/ionophor complex: alterations by ethanol in vitro and by chronic in vivo ethanol injestion. Brain Res 1993; 602: 91-98
• 19 Levin RM, Weiss B. Selective binding of antipsychotics and other psychoactive agents to the calcium dependent activator of cyclic nucleotide phosphodiesterase. J Parmacol Exp Ther 1979; 208: 454-459
• 20 Foster AC, Wong HF. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. British J Pharmacol 1987; 91: 403-409
• 21 MacIntyre DE, Pollock WK, Shaw AM, Bushfield M, MacMillan LJ, McNicol A. Agonist-induced inositol phospholipid metabolism and Ca²⁺ flux in human platelet activation. Adv Exp Med Biol 1985; 192: 127-144
• 22 Crawford NV, Scrutton MC. Biochemistry of the blood platelet. In: Hemostasis and Thrombosis, 2nd edn Bloom AL, Thomas DP. ed. Edinburgh:: Churchill Livingstone; 1987: 47-77
• 23 Bushfield M, McNicol A, MacIntyre DA. Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. Biochem J 1985; 232: 267-271
• 24 Cooper DMFE, Mons N, Karpen JW. Adenylyl cyclase and the interaction between calcium and cAMP signalling. Nature 1995; 374: 421-424
• 25 Resink TJ, Stucki S, Grigorian GY, Zschauer A, Buhler FR. Biphasic Ca²⁺ response to adenylyl cyclase. The role of calmodulin in its activation by Ca²⁺ ions. Europ J Biochem 1986; 154: 451-456
• 26 Grigorian GY, Resink TJ, Stucki S, Buhler FR. Calmodulin regulation of adenylyl cyclase activity in human platelet membranes. Cell Calcium 1986; 7: 261-273
• 27 Caldwell KK, Boyajian CL, Cooper DMF. The effects of Ca²⁺ and calmodulin on adenylyl cyclase activity in plasma membranes derived from neural and non-neural cells. Cell Calcium 1992; 13: 107-121